$AMWL

Schlegel Stephen J. sold $85K of AMWL

Schlegel Stephen J. sold 9,750 shares of American Well Corp (AMWL) at $8.76 on 2026-06-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schlegel Stephen J.
Published Jun 15, 2026, 9:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 9:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMWL
Neutral
medium confidence
Mentioned
$AMWL
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMWLNeutralLow
01

Why it matters

The newest disclosed fact is the director’s open-market sale details (shares, price, total value) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

This provides a fresh, primary-source datapoint on insider activity, but it is unlikely to drive a major repricing absent other catalysts.

03

What to watch

Traders may over-weight insider sales; without accompanying fundamentals (earnings, guidance, financing, litigation), the signal is usually weak.

Relevance 2/10Novelty 5/10Timing: Filed June 15; sale executed June 11

Background

The article is an SEC Form 4 insider transaction disclosure for American Well Corp (AMWL).

Company-level read

Ticker impact

$AMWLNeutralMedium confidence
Context

SEC Form 4 shows director Stephen J. Schlegel sold 9,750 AMWL shares in an open-market sale under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a primary-source insider transaction, but it is explicitly pre-arranged (10b5-1), reducing interpretive value versus discretionary selling.

Market effects

No sector-level read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • American Well Corp

    Subject of the SEC Form 4 insider transaction disclosure.

  • Stephen J. Schlegel

    Director who sold 9,750 shares of AMWL on June 11 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMWLMedAI 8/10

American Well (AMWL) Q2 2026 Earnings Call Transcript

American Well (AMWL) reported Q2 2026 revenue of $52 million, down 26.6% year over year, with subscription revenue of $25.7 million and AMG revenue of $24.4 million. Adjusted EBITDA loss was $1.15 million and net loss was $9.6 million. Full-year guidance was narrowed to $200-$205 million revenue and improved adjusted EBITDA loss to $9-$7 million. The Defense Health Agency issued an intent to award a sole-source contract.